• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS TROPONIN T HS; IMMUNOASSAY METHOD, TROPONIN SUBUNIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS TROPONIN T HS; IMMUNOASSAY METHOD, TROPONIN SUBUNIT Back to Search Results
Catalog Number 08469873190
Device Problems High Test Results (2457); Low Test Results (2458); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/06/2023
Event Type  malfunction  
Event Description
The initial reporter stated they received discrepant results for an unspecified number of patient samples tested with elecsys troponin t hs on two cobas e 801 analytical units between (b)(6) 2023 and (b)(6) 2023.Examples of patient data are provided for 5 patient samples.The first sample resulted in trponin t values of 16.2 ng/l and repeated as 9.0 ng/l on the first e 801 system.The sample was repeated a third time on an unknown system, resulting in a value of 12.1 ng/l.The second sample resulted in troponin t values of 6.5 ng/l and 7.0 ng/l when tested on the first e 801 system on (b)(6) 2023.The sample was repeated twice on the second e 801 analyzer, resulting in troponin t values of 14.8 ng/l and 7.1 ng/l.The sample was repeated five additional times on an unknown system, resulting in values of 14.8 ng/l, 10.8 ng/l, 20.7 ng/l, 7.9 ng/l, and 6.3 ng/l.The average of the last 2 values of 7.9 ng/l and 6.3 ng/l was reported outside of the laboratory as 7.1 ng/l.The third sample resulted in troponin t values of 47.7 ng/l and 128.0 ng/l on the first e 801 system on (b)(6) 2023.The sample was repeated a third time on an unknown system, resulting in a value of 129 ng/l.The fourth sample resulted in a troponin t values of 10.6 ng/l and 6.8 ng/l when tested on the first e 801 system on (b)(6) 2023.A third measurement of the sample was performed on an unknown system, resulting in a value of 6.55 ng/l.The fourth sample resulted in a troponin t values of 10.5 ng/l and 5.6 ng/l when tested on the second e 801 system on (b)(6) 2023.A third measurement of the sample was performed on an unknown system, resulting in a value of 4.25 ng/l.
 
Manufacturer Narrative
A serial number of (b)(6) was provided for one of the e 801 analyzers, but it is not known which of the two systems this applies to.The serial number of the second e 801 analyzer was requested, but not provided.The following troponin t reagent lot numbers were used on the first e 801 analyzer: lot 639807 between on (b)(6) 2023, lot 642405 between on (b)(6) 2023, lot 688155 between on(b)(6) 2023.The following troponin t reagent lot numbers were used on the second e 801 analyzer: lot 639807 between on (b)(6) 2023, lot 642405 between on (b)(6) 2023, lot 688155 between on (b)(6) 2023, lot 642405 on (b)(6) 2023, lot 688155 between on (b)(6) 2023.The reagent expiration dates were requested, but not provided.The investigation is ongoing.
 
Manufacturer Narrative
Upon review of the alarm trace from july to november 2023, multiple sample short, sample clot, and sample foam alarms were observed.These alarms indicate a possible sample quality issue.Sample camera images from the analyzer showed evidence of clots, fibrin, fibrinogen, particles, or dust for a majority of samples.The investigation could not identify a product problem.The cause of the event could not be determined.The issue is consistent with incorrect pre-analytic sample handling.
 
Manufacturer Narrative
The customer performed a study comparing troponin t measurements obtained with patient samples collected in standard heparin plasma tubes that are strongly centrifuged and samples collected in barricor heparin plasma tubes.In total, there were 13 troponin t measurements from 7 patients that were =5 ng/l higher in comparison to a different measurement method.Of these 7 patients, there was 1 patient who was ultimately diagnosed with acs and medical intervention was also initiated.There was no allegation of harm to any patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS TROPONIN T HS
Type of Device
IMMUNOASSAY METHOD, TROPONIN SUBUNIT
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key18049567
MDR Text Key327371822
Report Number1823260-2023-03492
Device Sequence Number1
Product Code MMI
Combination Product (y/n)Y
Reporter Country CodeNL
PMA/PMN Number
K201441NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 12/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number08469873190
Device Lot Number639807
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/12/2023
Initial Date FDA Received11/01/2023
Supplement Dates Manufacturer Received11/14/2023
12/15/2023
Supplement Dates FDA Received12/08/2023
12/15/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-